Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Sale to Agenus
$40 million+ with $10mm upfront
Sale of 31 ANDAs to ANI Pharmaceuticals
$12.5mm + Profit Share
Asia, Africa, MidEast, Latin America
Sale to Concordia Healthcare
March 10-12, 2014
BIO-Europe Spring (EBD Group)
March 10-13, 2014
DCAT Week ’14
New York, NY
March 25-26, 2014
Boston Business Development Conference (BBC)
February 19, 2014
Torreya Partners Announces Three Executive Promotions
November 25, 2013
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement
to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
November 18, 2013
Cardiome acquires Correvio LLC